Larry Magpantay

2.2k total citations
51 papers, 1.7k citations indexed

About

Larry Magpantay is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Larry Magpantay has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Pathology and Forensic Medicine and 17 papers in Immunology. Recurrent topics in Larry Magpantay's work include Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (17 papers) and HIV Research and Treatment (13 papers). Larry Magpantay is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (17 papers) and HIV Research and Treatment (13 papers). Larry Magpantay collaborates with scholars based in United States, South Africa and Japan. Larry Magpantay's co-authors include Otoniel Martı́nez-Maza, Elizabeth C. Breen, Steven A. Miles, Milan Fiala, Lisa P. Jacobson, Jay H. Bream, Tadamitsu Kishimoto, Charles S. Rabkin, James Sayre and Guanghao Liu and has published in prestigious journals such as Science, New England Journal of Medicine and Blood.

In The Last Decade

Larry Magpantay

49 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Larry Magpantay United States	19	601	393	317	293	289	51	1.7k
Ute‐Christiane Meier United Kingdom	25	332 0.6×	812 2.1×	750 2.4×	313 1.1×	310 1.1×	46	2.1k
James Liu United States	31	214 0.4×	230 0.6×	361 1.1×	261 0.9×	114 0.4×	119	2.8k
Ilaria Bacigalupo Italy	18	332 0.6×	101 0.3×	123 0.4×	221 0.8×	158 0.5×	43	1.0k
John C. Probasco United States	19	361 0.6×	101 0.3×	58 0.2×	168 0.6×	271 0.9×	67	1.5k
Marianna Cortese United States	18	357 0.6×	427 1.1×	948 3.0×	368 1.3×	274 0.9×	44	2.1k
Orietta Picconi Italy	15	567 0.9×	149 0.4×	419 1.3×	211 0.7×	322 1.1×	44	1.7k
Elizabeth A. Tindall United States	19	371 0.6×	702 1.8×	232 0.7×	415 1.4×	188 0.7×	35	3.3k
Virgil A. S. H. Dalm Netherlands	31	321 0.5×	978 2.5×	331 1.0×	561 1.9×	468 1.6×	128	2.9k
Mark Freedman United States	16	565 0.9×	331 0.8×	1.9k 5.9×	265 0.9×	170 0.6×	44	2.4k
Sonia Shah United Kingdom	21	103 0.2×	289 0.7×	126 0.4×	1.2k 4.0×	171 0.6×	50	2.6k

Countries citing papers authored by Larry Magpantay

Since Specialization

Citations

This map shows the geographic impact of Larry Magpantay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Magpantay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Magpantay more than expected).

Fields of papers citing papers by Larry Magpantay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Magpantay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Magpantay. The network helps show where Larry Magpantay may publish in the future.

Co-authorship network of co-authors of Larry Magpantay

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Magpantay. A scholar is included among the top collaborators of Larry Magpantay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Magpantay. Larry Magpantay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hwang, Amie E., Jun Wang, Jia Y. Wan, et al.. (2025). Adverse late outcomes in long-term survivors of young adult Hodgkin lymphoma (YAHL) compared to their unaffected co-twins. Leukemia & lymphoma. 66(7). 1254–1263.

Kleeman, Michael J., Meredith Franklin, Mandy Yao, et al.. (2025). Cross-sectional evaluation of exposure to ozone, nitrogen dioxide, and particulate mass levels on circulating immune markers in women in the California Teachers Study. Scientific Reports. 16(1). 1248–1248.

Epeldegui, Marta, Di Chang, Jeannette Y. Lee, et al.. (2023). Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes. 94(2). 165–173. 4 indexed citations

Magpantay, Larry, et al.. (2023). Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk. Frontiers in Immunology. 14. 1259007–1259007. 2 indexed citations

Martínez, Laura E., Shelly Lensing, Di Chang, et al.. (2021). Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study. Clinical Cancer Research. 27(16). 4642–4651. 8 indexed citations

Martínez, Laura E., Tracy R. Daniels‐Wells, Larry Magpantay, et al.. (2021). Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBV+ Human Primary B-cells. Molecular Cancer Therapeutics. 20(9). 1592–1602. 4 indexed citations

Wang, Sophia, Charlie Zhong, Marta Epeldegui, et al.. (2021). Host characteristics associated with serologic inflammatory biomarkers in women. Cytokine. 149. 155726–155726. 3 indexed citations

Peres, Lauren C., Mary K. Townsend, Brenda M. Birmann, et al.. (2021). Circulating Biomarkers of Inflammation and Ovarian Cancer Risk in the Nurses' Health Studies. Cancer Epidemiology Biomarkers & Prevention. 30(4). 710–718. 13 indexed citations

Epstein, Mara M., Bernard Rosner, Elizabeth C. Breen, et al.. (2018). Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies. Haematologica. 103(10). 1679–1687. 7 indexed citations

10.

Epeldegui, Marta, Larry Magpantay, William G. Cumberland, et al.. (2018). A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma. AIDS. 32(7). 945–954. 26 indexed citations

11.

Kim, Caron, Otoniel Martı́nez-Maza, Larry Magpantay, et al.. (2016). Immunologic evaluation of the endometrium with a levonorgestrel intrauterine device in solid organ transplant women and healthy controls. Contraception. 94(5). 534–540. 16 indexed citations

12.

Roos, Anneclaire J. De, Otoniel Martı́nez-Maza, Keith R. Jerome, et al.. (2013). Investigation of Epstein–Barr Virus as a Potential Cause of B-Cell Non-Hodgkin Lymphoma in a Prospective Cohort. Cancer Epidemiology Biomarkers & Prevention. 22(10). 1747–1755. 14 indexed citations

13.

Vendrame, Elena, Shehnaz K. Hussain, Elizabeth C. Breen, et al.. (2013). Serum Levels of Cytokines and Biomarkers for Inflammation and Immune Activation, and HIV-Associated Non-Hodgkin B-Cell Lymphoma Risk. Cancer Epidemiology Biomarkers & Prevention. 23(2). 343–349. 52 indexed citations

14.

Miller, Pamela S., Lorraine S. Evangelista, Joyce Newman Giger, et al.. (2013). Exhaustion, immuno-inflammation, and pathogen burden after cardiac surgery: An exploratory study. European Journal of Cardiovascular Nursing. 13(3). 211–220. 7 indexed citations

15.

Hussain, Shehnaz K., Weiming Zhu, Shen-Chih Chang, et al.. (2012). Serum Levels of the Chemokine CXCL13, Genetic Variation in CXCL13 and Its Receptor CXCR5, and HIV-Associated Non-Hodgkin B-Cell Lymphoma Risk. Cancer Epidemiology Biomarkers & Prevention. 22(2). 295–307. 45 indexed citations

16.

Roos, Anneclaire J. De, Dana K. Mirick, Kerstin L. Edlefsen, et al.. (2012). Markers of B-Cell Activation in Relation to Risk of Non-Hodgkin Lymphoma. Cancer Research. 72(18). 4733–4743. 40 indexed citations

17.

Mizwicki, Mathew T., Milan Fiala, Larry Magpantay, et al.. (2012). Tocilizumab attenuates inflammation in ALS patients through inhibition of IL6 receptor signaling.. PubMed. 1(3). 305–15. 61 indexed citations

18.

Breen, Elizabeth C., Shehnaz K. Hussain, Larry Magpantay, et al.. (2011). B-Cell Stimulatory Cytokines and Markers of Immune Activation Are Elevated Several Years Prior to the Diagnosis of Systemic AIDS–Associated Non-Hodgkin B-Cell Lymphoma. Cancer Epidemiology Biomarkers & Prevention. 20(7). 1303–1314. 100 indexed citations

19.

Breen, Elizabeth C., Larry Magpantay, Zheng Hu, et al.. (2006). Serum levels of molecules that are markers of B cell activation are elevated prior to the development of acquired immunodeficiency syndrome-associated non-Hodgkin's B cell lymphoma. Cancer Research. 66. 165–165. 1 indexed citations

20.

Breen, Elizabeth C., Julia R. Gage, Beichu Guo, et al.. (2001). Viral Interleukin 6 Stimulates Human Peripheral Blood B Cells That Are Unresponsive to Human Interleukin 6. Cellular Immunology. 212(2). 118–125. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact